Related Experiment Video
Updated: Apr 5, 2026

Utilizing Custom-designed Galvanotaxis Chambers to Study Directional Migration of Prostate Cells
Published on: December 7, 2014
Tectonic‑1 contributes to the growth and migration of prostate cancer cells in vitro
Zhijun Wang1, Yi Gao1, Yushan Liu1
1Department of Urology, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, P.R. China.
Abstract:
Tectonic‑1 (TCTN1) is an upstream gene involved in embryonic development. The aim of the present study was to investigate the effect of the TCTN1 gene on the viability and migration of prostate cancer cells. Lentivirus‑mediated short hairpin RNA (shRNA) was constructed to silence the expression of TCTN1 in PC‑3 and DU145 prostate cancer cells. Cell viability and proliferation were measured using MTT and colony formation assays, and the distribution of cells in phases of the cell cycle was determined using flow cytometry. Cell migration was detected using a Transwell assay. The results demonstrated that TCTN1 was widely expressed in several human prostate cancer cell lines. Knockdown of the TCTN1 gene by RNA interference markedly suppressed cell viability and colony formation in the PC‑3 and DU145 cell lines. Cell cycle progression was also arrested by TCTN1 silencing. In addition, knockdown of the TCTN1 gene led to the inhibition of cell migration in the two cell lines. These findings confirmed the direct association between the TCTN1 gene and prostate cancer growth in vitro. With further understanding and clinical investigation, this indicates the potential for future development of a novel marker for early detection and gene therapy for prostate cancer.
Insights
The Tectonic-1 (TCTN1) gene significantly impacts prostate cancer cell growth. Silencing TCTN1 reduces cancer cell viability, proliferation, and migration, suggesting its potential as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Tectonic-1 (TCTN1) is an embryonic development gene.
- Prostate cancer remains a significant health concern with ongoing research into its genetic drivers.
- Understanding novel gene functions in cancer progression is crucial for therapeutic development.
Purpose of the Study:
- To investigate the role of the Tectonic-1 (TCTN1) gene in prostate cancer cell viability and migration.
- To determine the effect of TCTN1 gene silencing on prostate cancer cell behavior in vitro.
- To explore TCTN1 as a potential therapeutic target or biomarker for prostate cancer.
Main Methods:
- Constructed lentivirus-mediated short hairpin RNA (shRNA) to silence TCTN1 expression.
- Utilized PC-3 and DU145 human prostate cancer cell lines.
- Assessed cell viability (MTT assay), proliferation (colony formation assay), cell cycle distribution (flow cytometry), and migration (Transwell assay).
Main Results:
- TCTN1 was found to be widely expressed in human prostate cancer cell lines.
- Knockdown of TCTN1 significantly suppressed cell viability and colony formation in PC-3 and DU145 cells.
- TCTN1 silencing led to cell cycle arrest and inhibited cell migration in both cell lines.
Conclusions:
- The Tectonic-1 (TCTN1) gene plays a direct role in promoting prostate cancer cell growth and migration in vitro.
- TCTN1 is a potential novel biomarker for early prostate cancer detection.
- TCTN1 warrants further investigation for its potential in developing new gene therapies for prostate cancer.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Tumor Microenvironment

